(IFG)] (6.5%) compared to that of previous studies [2] [3] [4] . However, this resembles the reports of prevalence (T2DM 8.1% -11.2% and IFG 5.9%) in other urban population based studies conducted at different points of time 6, 7 .
Introduction
Diabetes Mellitus (DM) is now recognized as a global health challenge of the 21 st century. The highest percentages of increases in diabetic prevalence are reported to be in developing nations, like that of South-East Asia regions 1 . Several small-scale population based studies conducted in Bangladesh have revealed an increasing trend of diabetes prevalence both in rural and urban communities2-7. A recent rural population based study 5 showed higher prevalence of diabetes (7.2%) and of impaired glucose regulation [both impaired glucose tolerance (IGT) and/or impaired fasting glucose
Materials and Methods
In the present study, 30 newly detected normotensive T2DM subjects, never treated with any hypoglycemic, anti-hypertensive or lipid lowering drugs, aged between 20 to 30 years were selected as untreated new cases (Group II). Age-and gender-matched 30 healthy subjects (healthy relatives or unrelated attendants of patients with normal blood glucose) having no family history of diabetes up to second generations were chosen as control (Group I). All the subjects were selected purposively from the outpatient department of BIRDEM.
All the biochemical tests were done in the Department of Cell and Molecular Biology, BIRDEM following standard methods and procedures 5 . Blood glucose level was measured by Glucose Oxidase method and serum Mg 2+ by Ion Sensitive Electrode Method by using NOVA-8 analyzer. Plasma lipids were measured by enzymatic-colorimetric methods. The high density lipoprotein cholesterol (HDL-c) was measured by phosphotungstic-precipitation methods. The low density lipoprotein cholesterol (LDL-c) was calculated by the Friedewald's equation 14 , given that none had TG level above 400 mg/dl. TG concentration of>400 mg/dl were excluded from the study. Besides, subjects taking medications known to affect lipid profile, or patients with known endocrinopathies, osmotic symptoms, history of ketosis, weight loss of>3 kg in preceding 3 months, microvascular complications, recent (<1 year) MI, acute coronary syndrome, stroke, severe co-morbid diseases (cancer and renal failure), alcohol consumption, or any other known major illness; liver disease, ALT>3 times normal were excluded. After obtaining informed consent, a detailed sociodemographic data, family history of diseases and medical history were recorded. Physical and clinical examinations were done on the very first day of visit and recorded in a predesigned questionnaire.
Data were expressed as Mean±SD. Statistical Dyslipidemia is frequently found in type T2DM as a feature of insulin resistance syndrome; one of the key elements of pathogenesis in T2DM. Moreover, this plays an important role in the development of atherosclerosis resulting in macrovascular complications (coronary heart disease) which is the leading cause of mortality and morbidity in diabetic subjects 8, 9 .
Different reports suggest that diabetes mellitus is also associated with disturbances in electrolyte metabolism. In patients with high fasting glucose, Na + and Mg 2+ tend to be lower while K + is higher. Among the three parameters, only serum Mg 2+ significantly correlate with the level of hemoglobin A 1C and thus may be related to long-term control of diabetes. Hypomagnesemia may worsen insulin resistance. The kidneys possibly lose their ability to retain magnesium during periods of severe hyperglycemia. The increased loss of magnesium in urine may then result in lower blood levels of magnesium 10 . Thus, magnesium depletion and insulin resistance result in a vicious cycle of worsening insulin resistance and decrease in intracellular Mg 2+ which limits the role of magnesium in vital cellular processes 10, 11 .
Among the clinical variables, poor glycemic control, prolonged duration, and coexisting hypertension have been proven as the potential predictors of dyslipidemia in T2DM 12 . However, recent studies have shown association of low serum magnesium with dyslipidemia in T2DM [13] [14] [15] [16] . A number of studies have also reported beneficial effects of magnesium supplementation on lowering plasma total cholesterol and LDLc and an increase of HDLc level 17, 18 . However, the number of such studies correlating all these parameters in DM patients in our country is limited and often underreported. Considering the above facts and the increasing prevalence of DM in Bangladesh, the present study was conducted with an objective to evaluate the serum magnesium, fasting sugar and lipid profile in T2DM cases and to compare them with those of controls and to correlate them, with other parameters. comparisons between different groups were made using t-test, and correlation co-efficient was calculated to determine the association between said variables. All the data were compiled and analyzed with SPSS 12.0. A p value <0.05 was considered as significant.
Results
The new untreated T2DM cases had significantly higher (p<0.001) mean fasting serum glucose (14.86 ± 5.0 mmol/l) than that of the controls (4.23 ± 0.67 mmol/l). Statistical analysis showed significant difference of serum magnesium (p<0.001) and LDL-c (p<0.01) between the study groups ( Table-I) . Correlation analysis registered no significant association of FSG to serum magnesium or lipid profile in control, but for the diabetic cases FSG showed significant negative correlation with serum Mg 2+ and total cholesterol (-0.720, -0.483; p = 0.0001& 0.007, respectively) as well as a positive relation with HDL Cholesterol (r = 0.440,p = 0.015). Similarly serum Mg 2+ depicted significant association in diabetic group where serum Mg 2+ was positively related to serum HDL-c (r =0.372, p = 0.042) only (Figure-1 HDLc. There was also a negative relation to TC and LDL-c which was statistically insignificant. On the other hand, Nasri et al 14, 15 showed significant inverse correlations of serum Mg 2+ with serum Total and LDL cholesterol, but non-significant correlations of serum Mg 2+ with serum Lp(a), HDL-c and TG. Another recent study simply compared serum Mg 2+ in T2DM with and without complications (mainly CAD) in contrast to a healthy control group revealing highly significant lower levels in complicated diabetic subjects 16 . Hence, despite of such controversies, it could be concluded that the lower levels of serum magnesium may have a bearing on the altered lipid levels even within the normal ranges.
This small scale study was undertaken to explore the level as well as interrelation of serum magnesium and the established common biochemical parameters namely lipid profile and fasting serum glucose in T2DM subjects. Depletion of serum Mg 2+ below the lower reference value was common for both healthy and the diabetic subjects with a highly significant statistical difference. Lower serum Mg 2+ level showed significant correlation with FSG and HDL-c in the newly diagnosed cases with no proven complications, which could be considered as a hidden link between the pathogenesis of diabetes and its progression towards certain complications. Large scale population based studies are necessary for further clarification of the facts. Meanwhile, estimation of serum Mg 2+ might be added to the routine biochemical monitoring along with lipid profile in T2DM subjects from the very first day of their diagnosis.
Discussion
In this study different values have been noticed in lipid parameters between the two groups, but within the normal reference ranges. The major lipid profile fractions; total cholesterol, triglyceride and LDL-c are considered desirable or normal up to 200 mg/dl, 150 mg/dl and 100 mg/dl respectively and HDL-c> 40 mg/dl for male and>50 mg/dl for female is considered low or abnormal 19, 20 . The mean values of TG and total cholesterol in both study groups were close to these reference limits. However, the mean LDL-c was significantly higher in diabetic groups. The HDL-c was also found below the desired reference limit for both diabetic and healthy control groups with no statistically significant difference. These observations are consistent with a recent local study which revealed that most of the respondents had total cholesterol and triglyceride within normal limit but majority had abnormal LDL-c (about 60%) and HDL-c (82%) level 21 . There was a fall of serum magnesium below the lower reference limit (1.7 to 2.4 mmol/l) in both diabetics and controls 16 . However, there were no set of reference values for serum Mg 2+ or lipid fractions in Bangladeshi population for valid comparison. Serum Mg 2+ was also found to be significantly lower in diabetics than controls 13 .
Fasting serum glucose (FSG) showed a significant inverse correlation to TC and a positive association with HDL-c in newly diagnosed cases of this study. But, a number of studies done to illustrate metabolic control of diabetes mellitus and serum lipid levels have shown just the opposite; positive relation with TC, LDL-c levels and negative relation with HDL-c 22, 23 . Indeed, studies with controversial reports are available as well showing no such correlation with cholesterol 24, 25 .
One of the major findings of the present study was a significant inverse correlation of serum Mg 2+ with FSG and a direct association with HDL-c in diabetic subjects only, like most of the studies referred earlier [13] [14] [15] [16] . Some of these have also showed the same in terms of FSG for controls as well 13 . Again, there is evidence of significant negative correlation with other lipid fractions in cases, but the observation differed from one another. Mishra et al 13 found a significant negative
